Chemoenzymatic synthesis of duloxetine and its enantiomer: Lipase-catalyzed resolution of 3-hydroxy-3-(2-thienyl) propanenitrile

Tetrahedron Letters

Volumn 44, Issue 25, 2003, Pages 4783-4787

  Kamal, Ahmed ^a   Khanna, G B Ramesh ^a   Ramu, R ^a   Krishnaji, T ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXY 3 (2 THIENYL)PROPANENITRILE; DULOXETINE; NITRILE; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG;

ARTICLE; CATALYSIS; ENANTIOMER; MITSUNOBU REACTION; SYNTHESIS;

EID: 0038443005     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(03)00945-6     Document Type: Article

References (39)

1. Molloy, B. B.; Schmiegel, K. K. Ger. Pat. 2,500,110; US Pat. 4,314,081.
2. Florey K. Analytical Profiles of Drug Substances. 19:1990;193-219 Academic Press, San Diego. and references cited therein.
3. Klieser E., Lehmann E., Heinrich K. Pharmacopsychiatry. 28:1995;14.
4. Wong D.T., Bymaster F.P., Engleman E.A. Life Sci. 57:1995;411.
5. Robertson D.W., Jones N.D., Swartzendruber J.K., Yang K.S., Wong D.T. J. Med. Chem. 31:1988;185.
6. Robertson D.W., Krushinski J.H., Fuller R.W., Leander J.D. J. Med. Chem. 31:1988;1412.
7. Foster, B. J.; Lavangnino, E. R. EP 52,492; GB 2,087,883; JP 82,114,555.
8. Zerbe R.L., Rowe H., Enass G., Wong D., Farid N., Lemberger L. J. Pharmocol. Exp. Ther. 232:1985;139.
9. Chouinard G., Annable L., Brawejn J. Psychopharmacology. 83:1984;126.
10. Chouinard G., Annable L., Brawejn J., Labonte A., Jones B., Mercier P., Belanger M.C. Psychopharmacol. Bull. 21:1985;73.
11. Robertson, D. W.; Wong, D. T.; Krushinski, J. H., Jr. Eur. Pat. Appl. EP 273,658, 1988; Chem. Abs. 1988, 109, 170224n.
12. Wong D.T., Robertson D.W., Bymaster F.P., Krushinski J.H., Reid L.R. Life Sci. 43:1988;2049.
13. Deeter J., Frazier J., Staten G., Staszak M., Weigel L. Tetrahedron Lett. 31:1990;7101.
14. Liu H., Hoff B.H., Anthonsen T. Chirality. 12:2000;26.
15. Wong D.T., Horng J.S., Bymaster F.P., Hauser K.L., Molloy B.B. Life Sci. 15:1974;471.
16. Hytell J. Prog. Neuro-Psychopharmacol. Biol. Psychiat. 6:1982;277.
17. Wong D.T., Threlkeld P.G., Best L.L., Bymaster F.P. J. Pharmacol. Exp. Ther. 222:1982;61.
18. Wong D.T., Bymaster F.P., Horng J.S., Molloy B.B. J. Pharmacol. Exp. Ther. 193:1975;804.
19. Fuller R.W., Hemrick-Luecke S.K., Snoddy H.D. J. Pharmacol. Exp. Ther. 269:1994;132 Wong, D. T. Eur. Pat. Appl. EP 759,299.
20. Fuller R.W., Hemrick-Luecke S.K., Snoddy H.D. J. Pharmacol. Exp. Ther. 269:1994;132 Wong, D. T. Eur. Pat. Appl. EP 759,299.
21. Pitsikas N. Curr. Opin. Invest. Drug (PharmaPress Ltd.). 2000;116.
22. Horrobin, D. R.; Lodu, C. PCT Int. Appl. WO 01 26,623.
23. Iyengar, S.; Muhlhauser, M. A.; Thor, K. B. PCT Int. Appl. WO 97 33,880.
24. Heilegenstrin, J. H.; Tollenson, G. G.; Wong, D. T. PCT Int. Appl. WO 96 12, 485.
25. James, S. P. U. S. US Pat. 5,776,969.
26. Michelson, D.; Tollefson, G. D. PCT Int. Appl. WO 99 59,593.
27. Wheeler W.J., Kuo F. J. Label Compd Radiopharm. 36:1995;213.
28. Berglund, R. A. EP 0650965, US 5362886, JP 1995 188065.
29. Kamal A., Khanna G.B.R., Ramu R. Tetrahedron: Asymmetry. 13:2002;2039.
30. Kamal A., Khanna G.B.R. Tetrahedron: Asymmetry. 12:2001;405.
31. Kamal A., Sandbhor M., Ramana K.V. Tetrahedron: Asymmetry. 13:2002;815.
32. Kamal A., Sandbhor M. Bioorg. Med. Chem. Lett. 12:2002;1735.
33. Kamal A., Damayanthi Y., Reddy B.S.N., Laxminarayana B., Reddy B.S.P. Chem. Commun. 1997;1015 Kamal, A.; Khanna, G. B. R.; Ramu, R.; Rao, M. V. US Patent Appl. No. 10/393,406.
34. Kamal A., Damayanthi Y., Reddy B.S.N., Laxminarayana B., Reddy B.S.P. Chem. Commun. 1997;1015 Kamal, A.; Khanna, G. B. R.; Ramu, R.; Rao, M. V. US Patent Appl. No. 10/393,406.
35. 2 at 0°C and allowed to warm to room temperature over a period of 12 h;
36. 4 in methanol at room temperature for 30 min gave the corresponding alcohol;
37. 2O (3:1) at room temperature and stirred for 4 h.
38. Abstract.
39. Brown H.C., Choi Y.M., Narasimhan S. J. Org. Chem. 47:1982;3153.